WEHI PhD Completion Seminar hosted by Professor Peter Gibbs

Dr Matthew Loft

PhD Student – Gibbs Laboratory, Personalised Oncology division, WEHI

The use of real-world data to aid in cancer therapy dosing, interactions, regulations, guide treatment decisions and predict survival outcomes in colorectal cancer

 

Davis Auditorium

Join via SLIDO enter code #WEHIphdcompletion

Including Q&A session

Followed by refreshments in tapestry Lounge

Colorectal cancer (CRC) represents a major health problem world-wide, and remains one of the leading causes of cancer deaths. Advances in therapy have resulted in significant gains in survival, both in the early-stage and metastatic setting, with the discovery of biomarkers including RAS mutations and MMR status helping to refine treatment selection and improve outcomes. Currently however, CRC treatment and prognostication is limited to several key factors and not truly personalised.

I am a Medical Oncologist working in both public and private health care. My additional degree in Pharmacy provides a unique perspective to clinical practice, anti-cancer therapeutics and research. My PhD has leveraged multi-site comprehensive datasets for CRC, analysing current treatments, including regulations, dosing and sequencing, and developing tools to better predict treatment response and survival probabilities and how these evolve over time from diagnosis, to move away from a “one sites fits all” approach and toward personalised patient prognostication, surveillance and treatment strategies.

All welcome!